source
- Merck-Kelun ADC scores survival win in Phase 3 gastroesophageal cancer trialLicensed from Kelun-Biotech, Merck’s TROP2-targeting antibody drug conjugate sac-TMT improved overall survival in advanced gastroesophageal cancer while missing on two secondary endpoints.BioSpace · 3h ago↗ source
- Early Alert: Heraeus Medical Components Removes Vascular GuidewiresVascular guidewire coating may displace or detach and enter patient bloodstream.fda medwatch · 13h ago↗ source
- FDA officials detail inspection expectations for combination productsBALTIMORE – US Food and Drug Administration (FDA) officials said that manufacturers who opt to follow a streamlined approach to their combination product current good manufacturing practice (CGMP)…